Cancer patients now have new hope for treatment with minimal side effects compared with conventional treatments such as chemotherapy.
Because the PT Kalbe Farma Tbk, today introduced the drug "targeted therapy" and was exploring the possibility of entering the drug in the list of Health Insurance (Askes).
According to Director of Innogene Kalbiotech Kalbe Farma, Rikrik Ilyas, targeted therapy is a cancer drug that can reduce side effects because the drugs directly to patients to target the cancer cells.
"The problem, targeted drug therapy is only used during certain circles because the price is relatively expensive," he said in a statement received VIVAnews.com in Jakarta, Thursday, May 19, 2011.
Imunopatologi Professor of University of Indonesia, Santoso Cornain added, usually cancer drugs have side effects such as anemia, hair loss, nausea, and diarrhea. However, the use of targeted therapies can reduce these side effects.
"As the name of targeted therapies, which attack only the cancer cells only, unlike conventional cancer drugs which, besides attacking the cancer cells also attack cells that are still healthy," he said.
Kalbe Farma through the biopharmaceutical division continues to develop and refine drugs and diagnostics that can minimize or reduce side effects for cancer patients. "We have Innogene Kalbiotech unit based in Singapore specializes in the research development of cancer drugs that can reduce side effects," said Rikrik.
Rikrik said that Singapore was chosen as the location because it gives tax breaks the company up to double the cost of research for cancer drugs are produced.
According to him, Kalbe has invested approximately Rp180 billion for drug development and diagnostic tools for cancer that has now entered in the eighth.
Some of these funds, approximately Rp60 billion used to establish biotechnology research institutions such as the Stem Cell & Cancer Institute and Kalgen (Kalbe Genomics) Laboratory.
Meanwhile, Hera Novianti, experts in the field of molecular biology, said some people with cancer caused by carrying the gene from their parents. Thus the provision of cancer drugs can not be equated and should be tailored to a person's genetic.
Hera added, Kalbe Genomic Laboratory have laboratories to check a person's genes so that cancer can be an effective drug delivery to the target at a cost ranging from 500 thousand to Rp 3, 5 million. This cost can still be reduced for participants Askes, because this gene has entered the examination Askes program.
Minimal Side Effects of Cancer Drug Ala Kalbe
This article
Minimal Side Effects of Cancer Drug Ala Kalbe
can be opened in url
http://transportation22.blogspot.com/2011/08/minimal-side-effects-of-cancer-drug-ala.html
Minimal Side Effects of Cancer Drug Ala Kalbe
